Study highlights potential of p-tau217 assays in Alzheimer’s clinical trials and diagnosis

FHS
March 14, 2024
10:03 am

The performance of two commercial phospho-tau217 (p-tau217) assays.

BeiGene’s TEVIMBRA receives approval for OSCC in Israel

TEVIMBRA monotherapy is indicated for treating unresectable or metastatic oesophageal squamous cell carcinoma. Credit: SewCreamStudio/Shutterstock. The Israeli Ministry of Health (IL MOH) has approved BeiGene’s

September 18, 2024

What to know about Trump VP pick J.D. Vance’s health care views and investments

WASHINGTON — Sen. J.D. Vance, who was tapped to be former President Trump’s running mate on Monday, has a history of investing in health care

July 15, 2024

WuXi AppTec will sell cell and gene therapy business to private equity firm

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.